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Abstract 
Background and Aim: Hepatitis B virus (HBV) is a human carcinogenesis agent. Interleukin 10 (IL-10) is a key anti-
inflammatory cytokine, and single nucleotide polymorphisms in IL-10 gene promoter are correlated with infections 
caused by HBV. This research intended to assess the prevalence and genotype of HBV as well as the association 
between the polymorphisms of -819 and -1082 in the IL-10 gene with HBV in individuals with HBV infection in Qom 
Province, Iran 
Methods: In this cross-sectional research, 360 individuals with chronic HBV infection and control group were 
involved between July 2018 and March 2019. HBV diagnosis was evaluated using ELISA and nested PCR assays. To 
determine polymorphisms in the IL-10 gene promoter in HBV positive and control samples, an allele-specific 
polymerase chain reaction technique was employed.  
Results: The constructed phylogenetic trees for the HBsAg gene revealed that all sequences under study belong to 
genotype D and also, the majority of HBV samples presented similar sequences to the Iranian samples. Genotype 
frequencies of TT, TC and CC (polymorphism -819) were 82.2%, 11.6% and 6.1% for patients and 85%, 10.5% and 
4.4% in control groups, respectively. Also, frequency of genotypes of AA, AG and GG (polymorphism -1082) were 
45%, 43.8% and 11.1% for patients and 42.2%, 46.1% and 11.6% in control groups, respectively.  
Conclusion: Here, we found no association among IL-10 gene polymorphisms in control and HBV-infected groups. 
However, more studies about the frequency of chronic HBV infection are necessary to be conducted. 
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Hepatitis B virus (HBV) is important human 
carcinogenesis since 1993 worldwide (1, 2). It 
belongs to the Hepadnaviridae family and 
Orthohepadnavirus genus (3). HBV genome 
contains double-stranded DNA; including the pol 
gene encoding viral polymerase, surface proteins 
encoding three carboxy-terminal HBV surface 
(HBs) proteins, and pre-core/core (pre-C/C) that 
encodes structural core protein. Also, it consists of 
an extra pre-core sequence (4). The ten genotypes 
(labeled A to J) and several subgenotypes of HBV 
have been identified based on virologic and 
epidemiological properties. In comparison with 
genotypes B and D, genotype A is associated with 
considerable loss of HBeAg and HBsAg due to 
interferon (IFN) therapy (2, 5). Shaving from 
barbers, tattooing, surgical instruments, perinatal, 
parenteral (especially via reuse of needles, receiving 
risky blood products) and sexual routes are the main 
reasons for HBV transmission (3, 6). Although 
HBsAg prevalence is decreasing due to vaccination 
and efficient therapy in some countries it varies 
geographically. An actual problem is the migration 
of the population which leads to prevalence changes 
in countries with known low endemicity (2). Based 
on the latest information, 350 million patients with 
HBV have estimated worldwide (7, 8). In Iran, the 
prevalence of HBV according to anti-HBc 
The Association between Interleukin-10 Gene Polymorphisms …                                                          Azad AR, et al. 
Archives of Medical Laboratory Sciences; Volume 7, 2021 (Continuous Volume)  2 
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License 
antibodies is 16.4% (9).Some studies mentioned 
that HBV can stimulate the immune system, which 
causes major inflammatory responses. A large body 
of evidence suggests that cytokine-mediated 
immune response is a key to achieve better clinical 
outcomes in patients with HBV infection. Several 
immune factors contribute to HBV infection like 
classical immune parameters, transforming growth 
factor-β (TGF-β), tumor necrosis factor-α (TNF-α), 
and interleukins family such as interleukin-6, 23 
and 35 (10). The immune system of the host is key 
for inhibiting inflammation by Interleukin-10 
secreted from T-lymphocytes (11). The levels of IL-
10 production determine immune regulation and the 
balance between the cellular and humoral responses 
(12). Polymorphisms in the regulatory regions of 
the cytokine genes have an important impact on 
their expression. Thus the cytokine genes 
polymorphisms have a major contribution in 
predicting disease susceptibility and clinical 
outcome (13). Enhanced secretion of IL-10 contains 
a protective influence against HBV infection. 
Nevertheless, IL-10 gene polymorphisms in the 
proximal promoter region influence secretion of IL-
10, which may enhance the HCC risk 
(hepatocellular carcinoma) (14). Some previous 
studies reported that different polymorphisms of IL-
10 can cause HBV infection (1). Three classic 
promoter haplotypes; (GCC, ACC, and ATA) in 
positions of -1082, -819, and -592 in the promoter 
region of the gene IL10 are identified among 
populations of the world (15). Several studies 
reported the impact of these SNPs in the anti-HBV 
response. In addition, Shu et al. in a recently 
conducted meta-analysis reported their clinical 
importance in HBV infection (16). This research 
aimed to investigate HBV genotype and the 
relationship among the polymorphisms of -819 and 
-1082 in the IL-10 gene with HBV infection.  
Methods 
Participants  
In our previous study, 1600 blood samples of HBV-
suspected cases were collected from clinical centers 
of Qom Province (Iran) between July 2018 and 
March 2019. By considering a 95% confidence 
interval and an estimated prevalence of 50%, the 
sample size was calculated using Cochran’s formula 
(9). The control group consisted of 180 healthy 
individuals according to the number of HBV-
positive patients. 
HBV detection  
The level of HBsAg (hepatitis B surface antigen) of 
blood samples was detected by an ELISA kit 
(Pishtazteb, Iran) (3). 
Viral DNA extraction and PCR assay 
In this research, PCR products of HBV-positive 
isolates were exposed to direct sequencing to 
approve the presence of HBV DNA in the blood 
samples of HBsAg-positive patients. HBV DNA 
was extracted using a genomic DNA extraction kit 
(Sinaclon, Iran) by following the protocol presented 
by the manufacture. The primers were designed for 
the HBs gene of HBV by GenRunner and CLC 
Sequence Viewer 6 (Table 1).  
Table 1. Sequences of applied primers 
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We used blood serum infected with HBV as the 
positive control. While, we extracted DNA from a 
HBV-negative serum for the negative control. In 
table 2, the instructions employed as the first and 
second round of nested PCR for the HBs gene are 
described.  
To approve the existence of the HBsAg gene, we 
subjected the PCR products of HBV positive 
samples to direct sequencing.  
Moreover, to determine the polymorphisms -819 
and -1082 in the IL-10 gene promoter in HBV 
positive and healthy control cases, the allele-
specific polymerase chain reaction (PCR) technique 
was employed (Table 2).The final volume of all 
PCR reactions was 25 µL, containing 5 µL of DNA, 
Master Mix (17 µL), 1 µL of each primer, and 1 µL 
of Taq polymerase (Life Technologies, Carlsbad, 
USA). All reaction mixtures (5 µL) run on 1% 
agarose gel with Safe Stain (GelRed®, California) 
in a UV transilluminator. 
Statistical analysis 
Data were analyzed by SPSS (Version 22.0) and 
Microsoft Excel version 2017. The level of 
significance in the t-test was considered at p < 0.05. 

























50°C 30s 35x 
 
53°C 30s 35x 
72°C 45s 35x 
 
72°C 45s 35x 
72°C 5min 1x 
 
















56°C 45s  35x 72°C 1min  35x 72°C 10min 1x 
°C: Celsius, min: minute, x: the cycle of reaction, s: second. 
 
Results 
In this cross-sectional research, 1600 blood samples 
collected from HBV-suspected patients (aged from 
20 to 67 years) referred to the clinical centers of the 
Qom Province are tested. A total of 180 (11.25%) 
(p <0.05) positive cases of HBsAg were identified 
(121 men (out of 980) and 59 women (out of 692) 
with the mean age of 32-38 years).  
 
Table 3. Frequency of genotypes in the regions -819 and -1082 of the IL-10 gene promoter in patient (HBV-positive) 
and in control (healthy) groups (n = 360). 
Locus Genotypes 
patient group (n=180) control group (n=180) 


































Genotype frequencies of TT, TC and CC 
(polymorphisms -819 in the IL-10 gene) were 
82.2%, 11.6% and 6.1% for patients and 85%, 
10.5% and 4.4% in control group, respectively. 
Also, genotype frequencies of AA, AG and GG 
(polymorphisms -1082 in the IL-10 gene) were 
45%, 43.8% and 11.1% for patients and 42.2%, 
46.1% and 11.6% in control group, respectively 
(Table 3; Figures 3 and 4).  
The amplification findings of the HBV HBs gene 
using the nested PCR technique are described in 
Figure 1. The constructed phylogenetic trees for the 
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HBsAg gene of HBV revealed that all sequences 
under study belong to genotype D and also, the 
majority of HBV samples were similar to the 
Iranian isolates' sequence (Figure 2). 
 
Figure 1. HBs gene amplification. Lane SM: 100 bp 
DNA ladder; Lane NC: negative control; Lanes 1-4 
and 6-8: 303 bp positive sample; Lane 5: negative 
sample; and Lane 9: 303 bp positive control. 
 
Figure 2. The constructed phylogenetic trees for the 
HBsAg gene of HBV. 
 
Figure 3. IL-10 Promoter Polymorphism -819 
amplification in some samples. Lane SM: 100 bp 
DNA ladder; Lanes 2T, 2C: heterozygous TC 
individuals (216 bp fragments); Lane 3C, 3T: 
homozygous TT individuals (3C without 216 bp 
fragment); and Lane 4T, 4C, 5C, 5T: homozygous TT 
individuals (4T, 5T without 216 bp fragment). 
 
Figure 4. IL-10 Promoter Polymorphism -1082 
amplification in some samples. Lane SM: 100 bp 
DNA ladder; Lanes 2A, 2G, 4G, 4A: heterozygous 
AG individuals (706 bp fragments); Lane 3G, 3A: 
homozygous AA individuals (3G without 706 bp 
fragment); and Lane 5A, 5G: homozygous GG 
individuals (5A without 216 bp fragment). 
Discussion 
HBV infection is an important health problem, 
which causes cirrhosis and hepatocellular 
carcinoma (17). HBV may cause various 
asymptomatic and symptomatic states such as 
progressive chronic HBV infection (18). 
The HBV antigen prevalence is estimated at 2.4, 
88.8, 37.5, 5.88, 11, and 6.72% in Pakistan, Brazil, 
Tehran Province (Iran), Bandar Abbas city (Iran), 
Hormozgan Province (Iran), and in Bushehr 
Province (Iran), respectively (8, 19-23). However, 
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in this research that was performed in the province 
of Qom, (Iran) 180 (11.25%) cases were positive 
for HBsAg. All sequences under study belong to 
genotype D and also, the majority of HBV samples 
were similar to Iranian samples concerning their 
sequence. Genotypes A, D, and F are reported as 
the most common genotypes in Brazil (8). 
Due to limitations related to the identification 
method and the sample size, the findings should be 
generalized with caution. Qom province is the 
desired destination of many immigrants and 
travelers from all around the country and African 
and Asian countries, in many of which several 
diseases are endemic due to their poor health 
infrastructures. 
Some recently performed studies mentioned 
particular immuno-modulatory cytokines such as 
IL-10 as major risk factors that contribute to 
determining the history of persistent HBV 
infections (16). Recently, it is well-proved that 
polymorphism within the IL10 promoter region 
affects the expression and serum levels of IL-10. 
Several studies have examined -1082A/G, -819T/C, 
and -592A/C (24). This study is the first study 
showing the relationship among polymorphisms of 
promoter genes of IL-10 (-819 T/C, -1082 A/G) and 
susceptibility to HBV in the province of Qom 
(Iran). Allele-specific PCR technique was employed 
to determine polymorphisms in the IL-10 gene 
promoter samples infected with HBV (n=180) and 
healthy controls (n=180). Genotypes frequency of 
TT, TC and CC were 82.2%, 11.6% and 6.1% for 
patients and 85%, 10.5% and 4.4% in control group, 
respectively. Also, genotypes frequency of AA, 
AG, and GG were estimated at 45%, 43.8% and 
11.1% for patients and 42.2%, 46.1% and 11.6% in 
the control group, respectively. The IL-10-1082 AA 
and -819 TT genotypes were the most common in 
the HBV-positive group. 
Still, there are discrepancies regarding the 
relationship between IL-10 gene polymorphism and 
HBV infection. However, IL-10 polymorphism is 
reported to be associated with enhanced risk of 
HCC in Korea, Taiwan, and Chin. In addition, 
Zhang et al. found a relationship between the IL-10 
polymorphism at -1082GA and susceptibility to 
HBV infection (1, 25, 26). 
In the analysis of polymorphisms in the regions  -
819/-1082, no considerable difference was found 
between patients and control groups, which is 
consistent with the studies by Sofian et al. (27),  
Bineshian et al. (28). However, some studies 
reported conflicting findings including Mirfakhar et 
al. (29), Rybicka et al. (24), Truelove et al. (15), 
Shu et al. (16), Gao et al. (30),  Moudi et al. (31), 
and Shin et al. (32), which can be attributed to the 
presence of other genotypes on HBV. Also, 
probably epidemiological and geographical 
parameters and patients' characteristics affect this 
association. 
The nested PCR method contains two sets of 
primers that should be used in two successive runs 
of PCR. The second set accelerates a secondary 
target through the first run product and limits non-
specific products (33). The findings of the present 
study indicated that nested PCR is a highly sensitive 
method. 
Conclusion 
To successful managing of the HBV infection, early 
diagnosis of disease using nested PCR technique is of 
crucial importance. Also, no considerable difference 
was found between patient and control groups 
concerning the frequency of interleukin 10 gene 
polymorphism. 
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